Dietary omega-3 PUFA and health: Stearidonic acid-containing seed oils as effective and sustainable alternatives to traditional marine oils

Molecular Nutrition and Food Research

Volumn 57, Issue 5, 2013, Pages 748-759

  Surette, Marc E ^a  

^a UNIVERSITÉ DE MONCTON   (Canada)

Author keywords

Cardiovascular disease; Fish oil; Inflammation; Stearidonic acid; Vegetable oil

Indexed keywords

FISH OIL; MEMBRANE PROTEIN; OMEGA 3 FATTY ACID; STEARIDONIC ACID; VEGETABLE OIL;

ANIMAL; CHEMISTRY; DIET; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MOUSE; PLANT SEED; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ANIMALS; DIET; FATTY ACIDS, OMEGA-3; FISH OILS; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; MICE; PLANT OILS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEEDS;

BUGLOSSOIDES ARVENSIS; GLYCINE MAX;

EID: 84876439479     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200706     Document Type: Review

References (103)

1. Calder, P. C., n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 2006, 83, 1505S-1519S.
2. Mozaffarian, D., Rimm, E. B., Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296, 1885-1899.
3. Kris-Etherton, P. M., Harris, W. S., Appel, L. J., Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106, 2747-2757.
4. Lee, K. W., Lip, G. Y., The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. QJM 2003, 96, 465-480.
5. Jump, D. B., Depner, C. M., Tripathy, S., Omega-3 fatty acid supplementation and cardiovascular disease. J. Lipid. Res. 2012, 53, 2525-2545.
6. Goldberg, R. J., Katz, J., A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 2007, 129, 210-223.
7. Whelan, J., Rust, C., Innovative dietary sources of n-3 fatty acids. Annu. Rev. Nutr. 2006, 26, 75-103.
8. Turchini, G. M., Nichols, P. D., Barrow, C., Sinclair, A. J., Jumping on the omega-3 bandwagon: distinguishing the role of long-chain and short-chain omega-3 fatty acids. Crit. Rev. Food Sci. Nutr. 2012, 52, 795-803.
9. Jenkins, D. J., Sievenpiper, J. L., Pauly, D., Sumaila, U. R. et al., Are dietary recommendations for the use of fish oils sustainable? Can. Med. Assoc. J. 2009, 180, 633-637.
10. Nichols, P. D., Petrie, J., Singh, S., Long-chain omega-3 oils-an update on sustainable sources. Nutrients 2010, 2, 572-585.
11. Miller, M. R., Nichols, P. D., Carter, C. G., n-3 Oil sources for use in aquaculture-alternatives to the unsustainable harvest of wild fish. Nutr. Res. Rev. 2008, 21, 85-96.
12. Vrinten, P., Wu, G., Truksa, M., Qiu, X., Production of polyunsaturated fatty acids in transgenic plants. Biotechnol. Genet. Eng. Rev. 2007, 24, 263-279.
13. Ursin, V. M., Modification of plant lipids for human health: development of functional land-based omega-3 fatty acids. J. Nutr. 2003, 133, 4271-4274.
14. Ruiz-Lopez, N., Haslam, R. P., Venegas-Caleron, M., Larson, T. R. et al., The synthesis and accumulation of stearidonic acid in transgenic plants: a novel source of 'heart-healthy' omega-3 fatty acids. Plant Biotechnol. J. 2009, 7, 704-716.
15. Kuhnt, K., Degen, C., Jaudszus, A., Jahreis, G., Searching for health beneficial n-3 and n-6 fatty acids in plant seeds. Eur. J. Lipid. Sci. Technol. 2012, 114, 153-160.
16. Guil-Guerrero, J. L., Garcia-Maroto, F. F., Gimenez-Gimenez, A., Fatty acid profiles from forty-nine plant species that are potential new sources of gamma-linolenic acid. J. Am. Oil Chem. Soc. 2001, 78, 677-684.
17. Singer, P., Berger, I., Wirth, M., Godicke, W. et al., Slow desaturation and elongation of linoleic and alpha-linolenic acids as a rationale of eicosapentaenoic acid-rich diet to lower blood pressure and serum lipids in normal, hypertensive and hyperlipemic subjects. Prostaglandins Leukot. Med. 1986, 24, 173-193.
18. James, M. J., Ursin, V. M., Cleland, L. G., Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am. J. Clin. Nutr. 2003, 77, 1140-1145.
19. Kelley, D. S., Nelson, G. J., Love, J. E., Branch, L. B. et al., Dietary alpha-linolenic acid alters tissue fatty acid composition, but not blood lipids, lipoproteins or coagulation status in humans. Lipids 1993, 28, 533-537.
20. Wang, C., Harris, W. S., Chung, M., Lichtenstein, A. H. et al., n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am. J. Clin. Nutr. 2006, 84, 5-17.
21. Anderson, B. M., Ma, D. W., Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis. 2009, 8, 33.
22. Surette, M. E., Koumenis, I. L., Edens, M. B., Tramposch, K. M. et al., Inhibition of leukotriene synthesis, pharmacokinetics, and tolerability of a novel dietary fatty acid formulation in healthy adult subjects. Clin. Ther. 2003, 25, 948-971.
23. Bazan, H. E., Bazan, N. G., Feeney-Burns, L., Berman, E. R., Lipids in human lipofuscin-enriched subcellular fractions of two age populations. Comparison with rod outer segments and neural retina. Invest Ophthalmol. Vis. Sci. 1990, 31, 1433-1443.
24. Lands, W. E., Inoue, M., Sugiura, Y., Okuyama, H., Selective incorporation of polyunsaturated fatty acids into phosphatidylcholine by rat liver microsomes. J. Biol. Chem. 1982, 257, 14968-14972.
25. Yamashita, A., Sugiura, T., Waku, K., Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells. J. Biochem. 1997, 122, 1-16.
26. Hishikawa, D., Shindou, H., Kobayashi, S., Nakanishi, H. et al., Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity. Proc. Natl. Acad. Sci. USA 2008, 105, 2830-2835.
27. Murakami, M., Taketomi, Y., Miki, Y., Sato, H. et al., Recent progress in phospholipase A(2) research: from cells to animals to humans. Prog. Lipid. Res. 2011, 50, 152-192.
28. Shindou, H., Hishikawa, D., Harayama, T., Yuki, K., Shimizu, T., Recent progress on acyl CoA: lysophospholipid acyltransferase research. J. Lipid. Res. 2009, 50 (Suppl), S46-S51.
29. Calder, P. C., Mechanisms of action of (n-3) fatty acids. J. Nutr. 2012, 142, 592S-599S.
30. Boyce, J. A., Eicosanoids in asthma, allergic inflammation, and host defense. Curr. Mol. Med. 2008, 8, 335-349.
31. Shimizu, T., Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 2009, 49, 123-150.
32. Haeggstrom, J. Z., Funk, C. D., Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem. Rev. 2011, 111, 5866-5898.
33. Riccioni, G., Bucciarelli, T., Mancini, B., Di Ilio, C. et al., Antileukotriene drugs: clinical application, effectiveness and safety. Curr. Med. Chem. 2007, 14, 1966-1977.
34. Khanapure, S. P., Garvey, D. S., Janero, D. R., Letts, L. G., Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr. Top. Med. Chem. 2007, 7, 311-340.
35. Schmitz, G., Ecker, J., The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid. Res. 2008, 47, 147-155.
36. Wada, M., DeLong, C. J., Hong, Y. H., Rieke, C. J. et al., Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J. Biol. Chem. 2007, 282, 22254-22266.
37. Serhan, C. N., Petasis, N. A., Resolvins and protectins in inflammation resolution. Chem. Rev. 2011, 111, 5922-5943.
38. Kohli, P., Levy, B. D., Resolvins and protectins: mediating solutions to inflammation. Br J. Pharmacol. 2009, 158, 960-971.
39. Weylandt, K. H., Chiu, C. Y., Gomolka, B., Waechter, S. F. et al., Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat. 2012, 97, 73-82.
40. Yaqoob, P., Shaikh, S. R., The nutritional and clinical significance of lipid rafts. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13, 156-166.
41. Kim, W., Fan, Y. Y., Barhoumi, R., Smith, R. et al., n-3 Polyunsaturated fatty acids suppress the localization and activation of signaling proteins at the immunological synapse in murine CD4+ T cells by affecting lipid raft formation. J. Immunol. 2008, 181, 6236-6243.
42. Wong, S. W., Kwon, M. J., Choi, A. M., Kim, H. P. et al., Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 2009, 284, 27384-27392.
43. Xiao, Y. F., Sigg, D. C., Leaf, A., The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ion channels as a potential mechanism. J. Membr. Biol. 2005, 206, 141-154.
44. Marchioli, R., Barzi, F., Bomba, E., Chieffo, C. et al., Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105, 1897-1903.
45. Siscovick, D. S., Lemaitre, R. N., Mozaffarian, D., The fish story: a diet-heart hypothesis with clinical implications: n-3 polyunsaturated fatty acids, myocardial vulnerability, and sudden death. Circulation 2003, 107, 2632-2634.
46. Deckelbaum, R. J., Worgall, T. S., Seo, T., n-3 fatty acids and gene expression. Am. J. Clin. Nutr. 2006, 83, 1520S-1525S.
47. de Urquiza, A. M., Liu, S., Sjoberg, M., Zetterstrom, R. H. et al., Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 2000, 290, 2140-2144.
48. Novak, T. E., Babcock, T. A., Jho, D. H., Helton, W. S. et al., NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am. J. Physiol. Lung Cell Mol. Physiol. 2003, 284, L84-L89.
49. Draper, E., Reynolds, C. M., Canavan, M., Mills, K. H. et al., Omega-3 fatty acids attenuate dendritic cell function via NF-kappaB independent of PPARgamma. J. Nutr. Biochem. 2011, 22, 784-790.
50. Caughey, G. E., Mantzioris, E., Gibson, R. A., Cleland, L. G. et al., The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am. J. Clin. Nutr. 1996, 63, 116-122.
51. De Caterina, R., Massaro, M., Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J. Membr. Biol. 2005, 206, 103-116.
52. Bang, H. O., Dyerberg, J., Nielson, A. B., Plasma lipid and lipoprotein pattern in Greenlandic West-Coast Eskimos. Lancet 1971, 1, 1143-1145.
53. Dyerberg, J., Bang, H. O., Lipid metabolism, atherogenesis, and haemostasis in Eskimos: the role of the prostaglandin-3 family. Haemostasis 1979, 8, 227-233.
54. Mozaffarian, D., Wu, J. H., (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? J. Nutr. 2012, 142, 614S-625S.
55. Niemoller, T. D., Bazan, N. G., Docosahexaenoic acid neurolipidomics. Prostaglandins Other Lipid Mediat. 2010, 91, 85-89.
56. SanGiovanni, J. P., Chew, E. Y., The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye. Res. 2005, 24, 87-138.
57. Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y. et al., Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369, 1090-1098.
58. Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M. et al., Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 2002, 346, 1113-1118.
59. Hu, F. B., Bronner, L., Willett, W. C., Stampfer, M. J. et al., Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002, 287, 1815-1821.
60. Mozaffarian, D., Lemaitre, R. N., King, I. B., Song, X. et al., Circulating long-chain omega-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study. Ann. Intern. Med. 2011, 155, 160-170.
61. Mozaffarian, D., Wu, J. H., Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 2011, 58, 2047-2067.
62. Sun, Q., Ma, J., Campos, H., Rexrode, K. M. et al., Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. Am. J. Clin. Nutr. 2008, 88, 216-223.
63. Miles, E. A., Calder, P. C., Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br. J. Nutr. 2012, 107 (Suppl 2), S171-S184.
64. James, M., Proudman, S., Cleland, L., Fish oil and rheumatoid arthritis: past, present and future. Proc. Nutr. Soc. 2010, 69, 316-323.
65. Larsson, S. C., Kumlin, M., Ingelman-Sundberg, M., Wolk, A., Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am. J. Clin. Nutr. 2004, 79, 935-945.
66. De Vries, C. E., van Noorden, C. J., Effects of dietary fatty acid composition on tumor growth and metastasis. Anticancer Res. 1992, 12, 1513-1522.
67. Wendel, M., Heller, A. R., Anticancer actions of omega-3 fatty acids-current state and future perspectives. Anticancer Agents Med. Chem. 2009, 9, 457-470.
68. Rose, D. P., Connolly, J. M., Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther. 1999, 83, 217-244.
69. Berquin, I. M., Edwards, I. J., Chen, Y. Q., Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett. 2008, 269, 363-377.
70. MacLean, C. H., Newberry, S. J., Mojica, W. A., Khanna, P. et al., Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 2006, 295, 403-415.
71. Gerber, M., Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies. Br. J. Nutr. 2012, 107 (Suppl 2), S228-239.
72. Harris, W. S., International recommendations for consumption of long-chain omega-3 fatty acids. J. Cardiovasc. Med. 2007, 8 (Suppl 1), S50-S52.
73. Taber, L., Chiu, C. H., Whelan, J., Assessment of the arachidonic acid content in foods commonly consumed in the American diet. Lipids 1998, 33, 1151-1157.
74. Trivelpiece, W. Z., Hinke, J. T., Miller, A. K., Reiss, C. S. et al., Variability in krill biomass links harvesting and climate warming to penguin population changes in Antarctica. Proc. Natl. Acad. Sci. USA 2011, 108, 7625-7628.
75. Sijtsma, L., de Swaaf, M. E., Biotechnological production and applications of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. Appl. Microbiol. Biotechnol. 2004, 64, 146-153.
76. Truksa, M., Wu, G., Vrinten, P., Qiu, X., Metabolic engineering of plants to produce very long-chain polyunsaturated fatty acids. Transgenic Res. 2006, 15, 131-137.
77. Sayanova, O., Napier, J. A., Transgenic oilseed crops as an alternative to fish oils. Prostaglandins Leukot Essent Fatty Acids 2011, 85, 253-260.
78. Kinney, A. J., Metabolic engineering in plants for human health and nutrition. Curr. Opin. Biotechnol. 2006, 17, 130-138.
79. Whelan, J., Dietary stearidonic acid is a long chain (n-3) polyunsaturated fatty acid with potential health benefits. J. Nutr. 2009, 139, 5-10.
80. Sato, S., Xing, A., Ye, X., Schweiger, B. et al., Production of gamma-linolenic acid and stearidonic acid in seeds of marker-free transgenic soybean. Crop Science 2004, 44, 646-652.
81. Hammond, B. G., Lemen, J. K., Ahmed, G., Miller, K. D. et al., Safety assessment of SDA soybean oil: results of a 28-day gavage study and a 90-day/one generation reproduction feeding study in rats. Regul. Toxicol. Pharmacol. 2008, 52, 311-323.
82. Barzanti, V., Maranesi, M., Cornia, G. L., Malavolti, M. et al., Effect of dietary oils containing different amounts of precursor and derivative fatty acids on prostaglandin E2 synthesis in liver, kidney and lung of rats. Prostagland. Leukot. Essent. Fatty Acids 1999, 60, 49-54.
83. Zhang, P., Boudyguina, E., Wilson, M. D., Gebre, A. K. et al., Echium oil reduces plasma lipids and hepatic lipogenic gene expression in apoB100-only LDL receptor knockout mice. J. Nutr. Biochem. 2008, 19, 655-663.
84. Yang, Q., O'Shea, T. M., Dietary Echium oil increases tissue (n-3) long-chain polyunsaturated fatty acids without elevating hepatic lipid concentrations in premature neonatal rats. J. Nutr. 2009, 139, 1353-1359.
85. Yamazaki, K., Fujikawa, M., Hamazaki, T., Yano, S. et al., Comparison of the conversion rates of alpha-linolenic acid (18:3(n-3)) and stearidonic acid (18:4(n-3)) to longer polyunsaturated fatty acids in rats. Biochim. Biophys. Acta. 1992, 1123, 18-26.
86. Kelavkar, U. P., Hutzley, J., Dhir, R., Kim, P. et al., Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia 2006, 8, 112-124.
87. Kelavkar, U. P., Hutzley, J., McHugh, K., Allen, K. G. et al., Prostate tumor growth can be modulated by dietarily targeting the 15-lipoxygenase-1 and cyclooxygenase-2 enzymes. Neoplasia 2009, 11, 692-699.
88. Petrik, M. B., McEntee, M. F., Johnson, B. T., Obukowicz, M. G. et al., Highly unsaturated (n-3) fatty acids, but not alpha-linolenic, conjugated linoleic or gamma-linolenic acids, reduce tumorigenesis in Apc(Min/+) mice. J. Nutr. 2000, 130, 2434-2443.
89. McEntee, M. F., Ziegler, C., Reel, D., Tomer, K. et al., Dietary n-3 polyunsaturated fatty acids enhance hormone ablation therapy in androgen-dependent prostate cancer. Am. J. Pathol. 2008, 173, 229-241.
90. Weldon, K. A., Whelan, J., Allometric scaling of dietary linoleic acid on changes in tissue arachidonic acid using human equivalent diets in mice. Nutr. Metab. (Lond) 2011, 8, 43.
91. Rymer, C., Hartnell, G. F., Givens, D. I., The effect of feeding modified soyabean oil enriched with C18 : 4 n-3 to broilers on the deposition of n-3 fatty acids in chicken meat. Br. J. Nutr. 2011, 105, 866-878.
92. Institute of Medicine FaNB, Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids, National Academy Press, Washington, DC 2010.
93. Kitessa, S. M., Young, P., Echium oil is better than rapeseed oil in enriching poultry meat with n-3 polyunsaturated fatty acids, including eicosapentaenoic acid and docosapentaenoic acid. Br. J. Nutr. 2009, 101, 709-715.
94. Harris, W. S., DiRienzo, M. A., Sands, S. A., George, C. et al., Stearidonic acid increases the red blood cell and heart eicosapentaenoic acid content in dogs. Lipids 2007, 42, 325-333.
95. Harris, W. S., Lemke, S. L., Hansen, S. N., Goldstein, D. A. et al., Stearidonic acid-enriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker. Lipids 2008, 43, 805-811.
96. Krul, E. S., Lemke, S. L., Mukherjea, R., Taylor, M. L. et al., Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content. Prostagland. Leukot. Essent. Fatty Acids 2012, 86, 51-59.
97. Lemke, S. L., Vicini, J. L., Su, H., Goldstein, D. A. et al., Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety. Am. J. Clin. Nutr. 2010, 92, 766-775.
98. Miles, E. A., Banerjee, T., Calder, P. C., The influence of different combinations of gamma-linolenic, stearidonic and eicosapentaenoic acids on the fatty acid composition of blood lipids and mononuclear cells in human volunteers. Prostagland. Leukot. Essent. Fatty Acids 2004, 70, 529-538.
99. Miles, E. A., Banerjee, T., Dooper, M. M., M'Rabet, L. et al., The influence of different combinations of gamma-linolenic acid, stearidonic acid and EPA on immune function in healthy young male subjects. Br. J. Nutr. 2004, 91, 893-903.
100. Surette, M. E., Edens, M., Chilton, F. H., Tramposch, K. M., Dietary echium oil increases plasma and neutrophil long-chain (n-3) fatty acids and lowers serum triacylglycerols in hypertriglyceridemic humans. J. Nutr. 2004, 134, 1406-1411.
101. Diboune, M., Ferard, G., Ingenbleek, Y., Tulasne, P. A. et al., Composition of phospholipid fatty acids in red blood cell membranes of patients in intensive care units: effects of different intakes of soybean oil, medium-chain triglycerides, and black-currant seed oil. Parenter Enteral. Nutr. 1992, 16, 136-141.
102. Harris, W. S., Von Schacky, C., The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev. Med. 2004, 39, 212-220.
103. Chilton-Lopez, T., Surette, M. E., Swan, D. D., Fonteh, A. N. et al., Metabolism of gammalinolenic acid in human neutrophils. J. Immunol. 1996, 156, 2941-2947.